Cargando…
N-acetylcysteine lacks universal inhibitory activity against influenza A viruses
N-acetylcysteine (NAC) has been recently proposed as an adjuvant therapeutic drug for influenza pneumonia in humans. This proposal is based on its ability to restrict influenza virus replication in vitro and to attenuate the severity of the disease in mouse models. Although available studies were ma...
Autores principales: | Garigliany, Mutien-Marie O, Desmecht, Daniel J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104374/ https://www.ncbi.nlm.nih.gov/pubmed/21554703 http://dx.doi.org/10.1186/1477-5751-10-5 |
Ejemplares similares
-
Interferon-induced Sus scrofa Mx1 blocks endocytic traffic of incoming influenza A virus particles
por: Palm, Mélanie, et al.
Publicado: (2010) -
Schmallenberg Virus in Domestic Cattle, Belgium, 2012
por: Garigliany, Mutien-Marie, et al.
Publicado: (2012) -
Influenza A Strain-Dependent Pathogenesis in Fatal H1N1 and H5N1 Subtype Infections of Mice
por: Garigliany, Mutien-Marie, et al.
Publicado: (2010) -
Natural Intrauterine Infection with Schmallenberg Virus in Malformed Newborn Calves
por: Bayrou, Calixte, et al.
Publicado: (2014) -
New Insights into the Susceptibility of Immunocompetent Mice to Usutu Virus
por: Benzarti, Emna, et al.
Publicado: (2020)